The role of proteases in viral infection of the lung is poorly understood. Thus, we examined matrix metalloproteinases (MMPs) and cathepsin proteases in respiratory syncytial virus (RSV)-infected mouse lungs. RSV-induced gene expression for , and -28 and cathepsins B, C, E, G, H, K, L1, S, W, and Z in the airways of Friend leukemia virus B sensitive strain mice. Increased proteases were present in the bronchoalveolar lavage fluid (BALF) and lung tissue during infection. Mitochondrial antiviral-signaling protein (MAVS) and TIR-domain-containing adapter-inducing interferon-b-deficient mice were exposed to RSV. Mavs-deficient mice had significantly lower expression of airway MMP
INTRODUCTION
Microbial infections in the airways contribute to tissue remodeling and are also a major factor in exacerbating underlying diseases, which have been associated with cytokine and chemokine release from resident lung cells. 1 A protease/ antiprotease imbalance can equally be associated with inflammation and extracellular matrix degradation. 2 Proteases have a number of functional effects that contribute to tissue destruction including tissue remodeling, cleavage of soluble innate factors, and activation of receptors. Alternatively, proteases also have a critical role in microbial clearance as neutrophil proteases are critical for microbial killing. 3 However, some proteases may even facilitate viral entry and replication into human cells. 4 Thus, determining how viral infection impacts on protease expression, release, and activity and the subsequent protease effects on immune responses and lung microenvironment remain important areas to explore.
Matrix metalloproteinases (MMPs) and cathepsins are clinically important proteases that are elevated in many diseases. MMPs are produced by a wide variety of cell-types, including epithelium, fibroblasts, neutrophils, and macrophages. 5 MMPs act on a variety of non-matrix extracellular proteins, such as cytokines, chemokines, receptors, junctional proteins, and antimicrobial peptides, to mediate a broad range of biological processes, such as repair, immunity, and angiogenesis. 5 Similarly, cathepsins are produced by several cell-types and tissues and are known to undergo activation by cytokines. 6 Respiratory syncytial virus (RSV) is a virus frequently reported in infants, the elderly, immunocompromised patients as well as healthy adults. 7 Infection alters protease profiles, with MMP-3 and -10 expression being sensitive to RSV inoculation in nasal epithelial cells 8 and MMP-3 levels in nasopharyngeal aspirates are associated with RSV disease severity. 9 RSV induces MMP-9 gene expression in human bronchial epithelial cells 10 and MMP-9 and -2 were activated by RSV in BALB/c mouse. 11 Bovine RSV can act synergistically with Histophilus somni supernatant to elevate MMP-1 and -3 levels, leading to enhanced collagen breakdown and facilitating viral infection efficiency in bovine alveolar type-2 cells. 12 Therefore, previous studies show that RSV induces several proteases and suggest that RSV-inducible proteases may have a major role in disease progression. Proteases become expressed in response to microbial product stimuli 13 with pathogen recognition receptors having a major role in protease gene regulation when utilizing microbial mimicking agonists. 14, 15 Pathogen recognition receptors, such as toll-like receptors (TLR) and retinoic acid-inducible gene-1 (RIG-I)-like receptors (RLRs), induce major signaling cascades in response to viral stimulation. 16 Both TLR-mediated TIR-domain-containing adapter-inducing interferon-b (Trif) signaling and RLR can modulate similar immune processes to regulate cytokine production. 17, 18 The viral load of RSV correlates with the messenger RNA levels of the RLR, RIG-I. 19 RIG-I and melanoma differentiation-associated protein 5 (MDA5) activate the mitochondrial antiviral-signaling protein (MAVS) to trigger an antiviral response. 20 However, little is known about the role of pathogen recognition receptors in RSV-induced protease expression; although proteases have been shown to modulate TLR3 and RIG-I signaling 21 and inhibition of MMP-9 activity in bronchial epithelial cells prevents syncytia formation and blocks RSV multiplication. 10 Therefore, profiling the protease response during RSV infection and characterizing their regulation and role in disease progression may be beneficial for future treatment of RSV infection.
In this study, we investigate MMP and cathepsin expression responses to RSV infection. In vivo and in vitro approaches were utilized to identify the major regulatory signaling pathways in RSV-induced protease expression. The influence of Trif and MAVS signaling pathways were examined on RSVinduced protease expression, with RLR-dependent MAVS signaling observed to have a major role in RSV-induced MMP and cathepsin expression. These findings indicate that viral infections significantly enhance host protease responses, in a type-I interferon-dependent mechanism. Furthermore, we show that the RLR pathways are key players in the host protease response to viral infection and inhibition of proteases may be beneficial in clearing RSV from the airways.
RESULTS

RSV infection induces MMP and cathepsin expression and activity
Increased protease levels have been frequently observed in human airway diseases 22 and have a critical role in microbial killing. 3 While it is established that a viral-induced host proteases response occurs, when and which proteases are induced in RSV-infected lungs is not yet elucidated. Here we show that mice exposed to RSV infection have increased airway collagenase and elastase activity in their bronchoalveolar lavage fluid (BALF) (Figure 1a) . Elastase activity was observed as early as 24 h post infection. Both elastase and collagenase activity persisted beyond 9 days post RSV challenge. Protease activity mimicked the RSV N copy number and viral titer within the lung tissue, with reduced protease activity observed upon RSV clearance (Figure 1b) . RSV-infected mice also lost weight during infection ( Figure 1c ) and had increased BALF immune cell infiltration (Figure 1d ). Not surprisingly, RSV infection resulted in an infiltration of macrophages, neutrophils, and lymphocytes into the lung (Figure 1d,e) .
The influence of viral infection on protease expression was investigated in greater detail via quantitative PCR (qPCR) by examining the MMP and cathepsin families of proteases. Mice infected with RSV have significant gene expression increases for MMP-2, -3, -7, -8, -9, -10, -12, -13, -14, -16, -17, -19, -20, -25, -27, and -28 (Figure 2a-h) . Additionally, cathepsins B, C, E, G, H, K, L1, S, W, and Z were all enhanced by RSV infection (Figure 2i-m) . Of note, 9 days post RSV lung infection MMPs -2, -8, -9, -10, -12, -13, -14, -16, -19, -25, -27, -28 and cathepsins E, G, K, L1, S, W, and Z remained significantly increased in RSV-infected lungs ( Figure 2 ). Protein analysis was performed to confirm qPCR data. As illustrated in Figure 3 , RSV infection enhanced BALF and lung tissue MMP and cathepsin protein levels and activity. MMP-2, -3, -8, -9, and -12 BALF protein levels were quantified by multiplex analysis (Figure 3a) . RSV infection increased BALF gelatinase activity, which demonstrated an early MMP-9 response and a later MMP-2 response to RSV challenge ( Figure 3b) . Western blot on lung tissue confirmed that RSV exposure increased cathepsin E, S, G, K, B, W, and Z levels 7 days post infection (Figure 3c) . Cathepsin B, G, and S activity levels were elevated in BALF from RSV-infected mice (Figure 3d ).
RSV induces the MAVS/MDA5/RIG-I/TLR3 pathways in mouse lungs
RSV increased protein levels of MDA5, RIG-I, MAVS, MyD88, and Trif ( Figure 4a) . Additionally, phosphorylation of intereferon beta (IFN-b) regulatory factor 3 and TANK-binding kinase 1 were observed following RSV infection (Figure 4a ). Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) and activator protein 1 activity were induced by RSV 24 h post challenge and continued to persist beyond 9 days (Figure 4b ). As the TLR3/4 and RLR pathways were altered by RSV, 19 Trif and Mavs knockout (KO) mice were used to examine the importance of these pathways on protease production in vivo. Mavs KO mice were utilized as MAVS links RIG-I and MDA5 to antiviral effectors responses. Trif KO mice were chosen as both TLR3 and TLR4 are activated by RSV and are the only TLRs that utilize Trif signaling. Mice were exposed to RSV and killed every second day until 9 days post RSV challenge. Gene expression studies were performed on days post RSV challenge that corresponded with the maximal level of gene expression for each protease as determined in Figure 2 . Loss of Mavs expression prevented RSV-induced MMP-2, -3, -7, -8, -9, -10, -12, -13, and -28 and cathepsins C, G, K, S, W, and Z gene expression ( Figure 5 tissue on day 9 following infection compared with wild-type mice (Figure 6d ).
Type-I interferon responses regulate RSV-induced protease expression in human small airway epithelial (SAE) cells RSV is known to readily infect the airway epithelium 23 and is detectible in the airways using immunofluorescence (Figure 7a ). Therefore to confirm our in vivo findings and identify which RLR is regulating MAVS-induced protease production, human airway epithelial cells were infected with RSV and protease expression profiles were analyzed by qPCR ( Figure 7) . Gene expression for MMP-1, -3, -7, -8, -9, -10, 12, and 13 were induced in SAE cells upon RSV infection Figure S2) .
Since RSV induced a wide range of the proteases in a similar manner to that observed in vivo, SAE cells were transfected with silencing RNA (siRNA) for Trif, MDA5, RIG-I, laboratory of genetics and physiology 2 (LGP2), and MAVS (see Supplementary Figure S3 for siRNA transfection efficiency) to confirm the in vivo data and also to determine the RLR responsible for this protease induction. Several of the siRNAs altered protease expression, however RIG-I and MAVS expression were critical for the majority of RSV-induced proteases ( Table 1) . This is of interest, as RSV viral load correlates with RIG-I messenger RNA levels in a study of bronchiolitis in infants. 19 In fact, overexpression of RIG-I in SAE cells upregulated the same proteases as RSV stimulation (Figure 8) . Therefore, these results show Densitometry analysis was performed against actin or total protein (TBK1 and IRF3) levels for all samples from multiple immunoblots. (b) Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) and activator protein 1 (AP-1) nuclear activity levels were determined in the lung tissue of mock-and RSV-treated mice. Graphs are represented as mean ± s.e.m., where each measurement performed three times on 12 animals per group. *Represents a P-valueo0.05 compared with mock-treated mice on each corresponding day.
that RLRs, such as RIG-I, have a major role in RSV-mediated protease expression.
As RIG-I signaling regulates RSV-induced protease expression, type-I interferon stimulus was examined for induction of protease expression. SAE cells treated with 1,000 units of recombinant human IFN-b lead to gene expression induction of the same proteases seen in RSV stimulation (Figure 8c,d) . Inhibition of protease activity enhanced RSV clearance from the airways Protease inhibitors were utilized in vivo to assess the functional role of enhanced proteases in the airways during RSV infection.
Wild-type animals were administered a MMP inhibitor (batimastat) or cathepsin inhibitor (E64) daily during RSV infection. Batimastat, a potent inhibitor of MMP -1, -2, -3, -7 and -9, and E64, an effective cysteine protease inhibitor, were (c) RSV infection resulted in a drop in body weight in all animal groups and (d) a significant increase in the viral load 9 days post RSV challenge in the Mavs knockout (KO) mouse group compared with mock-treated mice. Graphs are represented as mean ± s.e.m., where each measurement was performed three times on 12 animals per group. P-values shown comparing both treatments connected are by a line. *Represents a P-valueo0.05 comparing Mavs KO mice to wild-type mice 9 days post RSV challenge.
intraperitoneal administered daily. An antiviral drug, ribavirin, was also administered to a group of animals as ribavirin is administered to patients with severe RSV infection. Also, ribavirin can inhibit MMP-9 activity in THP-1 cells. 24 Animals were killed 7 days post RSV challenge and all measurements were carried out on this day. In vivo administration of batimastat and E64 significantly inhibited protease activity in the airways (Figure 9a,b) . Interestingly, ribavirin treatment prevented protease activity in mouse airways during RSV infection (Figure 9a,b) . This inhibition was comparable to both the protease inhibitors. Animals receiving a protease inhibitor or ribavirin did not lose weight during the week of infection and demonstrated faster clearance of RSV from the airways (Figure 9c,d) . Surprisingly, there were reduced immune cells recruited to the airways in animals receiving protease inhibitor or ribavirin (Figure 9d) . Inhibition of proteases also subdued RSV-induced airway hyperresponsiveness, demonstrated by respiratory system resistance measurements during a metacholine dose challenge (Figure 9e) . Interleukin (IL)-4 has a major role in allergic response to RSV infection resulting in the development of airway hyperresponsiveness and lung eosinophilia. 25 Animals receiving a protease inhibitor or ribavirin had reduced IL-4 responses to RSV (Figure 9f) , which may contribute to the changes in airway hyperresponsiveness to RSV. IFN-b levels were unaltered in all animal groups infected with RSV ( Figure 9f) .
DISCUSSION
Several studies have investigated the induction of proteases by RSV as early as 1999, 26 but the role of these protease families in disease severity and viral clearance has not been established. We characterized how two families of proteases respond to RSV infection and demonstrate that the induction of proteases by RSV is primarily regulated by RLRs, such as RIG-I, in a type-I-dependent manner. Prior to this study, RSV infections were known to induce proteases, such as neutrophil elastase 26 and MMP-9, 11 but little was known about the influence of RSV infection on protease expression and the subsequent impact on the lung. We demonstrated that RSV induces expression of protease networks that contribute to disease progression. This study highlights the impact of RSV infection on the proteolytic response within the airways and the potential to target proteases to treat RSV infection.
Prior to undertaking this study, we believed that RSVinduced proteases were enhanced via a TLR3-/Trif-dependent manner, as polyinosinic-polycytidylic acid, a synthetic analog of double-stranded RNA, enhanced several MMPs 14,15 and TLR3/Trif are significantly induced by RSV. However, TLR3/Trif only partially regulated the protease response and RIG-I exerted a far more substantial effect on airway proteases responses. RLRs largely recognize double-stranded RNA, which is produced during the replication of many viruses. 27 Sendai virus defective interfering RNA 28 and the genomic ''panhandle'' structure of influenza virus 29 activate RLR signaling. It has been speculated that these ''panhandle'' structures allow negative-strand RNA viral genomes to achieve partially double-stranded RNA. 30 Exactly how RNA triggers the RLR pathway for most RNA viruses, including RSV, is yet to be identified. In rhinovirus studies, the bronchial epithelium antiviral response initially requires recognition of rhinovirus infection by TLR3/Trif and a subsequent RNA helicases response, 16 suggesting a contribution of both pathways. Indeed, represent two plausible and distinct mechanisms to induce protease production. Therefore, MAVS not only links RIG-I and MDA5 to antiviral effector responses, MAVS can also regulate the RIG-I-inducible proteases response to RSV observed in this study.
Recently, investigators have identified several proteases associated with RSV infection, such as MMP-2, -3, -9, and -10. [8] [9] [10] [11] We have identified that RSV enhances MMP-2, -3, -7, -8, -9, -10, -12, -13, -14, -16, -17, -19, -20, -25, -27, -28 and cathepsins B, C, E, G, H, K, L1, S, W, and Z levels in mouse airways. Whether all of these proteases are present in human viral exacerbations or contribute to disease progression is not yet known but each protease represents many potential future topics of interest. Also it should be noted that RSV gave a robust MMP-1 induction in SAE cells, which could not be evaluated in vivo, as mice express no MMP-1. Indeed, the protease profile in mice and epithelial cells differed with expression for MMP-2, -14, -17, -20, -25, -27, -28 and cathepsins B, C, H, L1, S, W, and Z, but it is not surprising as other residential cells or infiltrated immune cells could also contribute to protease production in response to RSV. The functional role of proteases in airway remodeling is well 5 but the impact of so many proteases on the microenvironment of the lung is unclear. Our data demonstrates that inhibition of protease activity aids in viral clearance and others have demonstrated that inhibition of MMP-9 activity prevents syncytia formation and blocks RSV multiplication, 10 which suggests that resolving the select protease activity in RSV infection is beneficial. These data strengthen the case for the use of protease inhibitors to treat RSV infections. Identifying the exact protease(s) responsible for aiding viral infectivity represents a major future area of investigation. Ribavirin administration to mice prevented the activity of proteases and also gene expression of several proteases, including MMP-9, -10, -12 and cathepsins B, C, and S (Supplementary Figure S4) . Expression of MMP-9 represents the most likely candidate for the changes in the phenotype observed in our study as MMP-9 KO mice have reduced airway hyperresponsiveness, 32 and inhibition of MMP-9 blocks RSV 10 and fellow Paramyxoviruses such as the Sendai virus. 33 Other viruses have been documented to induce protease responses. Indeed, the induction of MMP-9 by Influenza A virus was associated with severe lung pathology in mice 34 and the regulation of neutrophil migration. 35 Also, MMP-9 is higher in children with mumps meningitis. 36 Sendai virus increases MMP-9 activity to drive pneumonia progression by enhancing virus multiplication and aids in the destruction of lung matrix in rats. 33 Whether other viruses lead to the induction of similar host proteases as the RSV or play a similar role in disease progression is a major topic for discussion. Our in vitro RIG-I overexpression experiment suggests that multiple viruses, which trigger a RIG-I response, may observe a similar protease response. Also, polyinosinic-polycytidylic acid triggers the expression of multiple MMPs, 15 which further suggests the potential for similar mechanistic protease induction. Other pathogen recognition receptor ligands can induce expression of proteases, such as lipopolysaccharide induction of MMP-1 14, 15 or the induction of multiple TLR ligands involved in MMP-9 expression.
14 Therefore, the protease profile induced by other microorganisms and the role of subsequent induced proteases in disease progression remains to be an intriguing area for future study. RSV could also induce many other proteases outside of the MMP and cathepsin families. Neutrophil elastase has been documented to be elevated in the upper airways of infants infected with RSV. 26 Similarly, we observed increased elastase activity following RSV infection, which may not only be due to the increased MMP-12 levels. Interestingly, RSV does induce ADAM17 in mouse airways (Supplementary Figure S5A) . RSV induction of membrane localized ADAM protease activity has been linked to the activation of extracellular signal-regulated kinase and IL-8 production in a EGFR-dependent manner. 37 In our in vitro models RSV also induced emmprin, an inducer of MMP synthesis (Supplementary Figure S5B) . Emmprin expression affects the production of MMPs 38 and its expression has been linked to pulmonary fibrosis progression 39 and may contribute to the signaling outlined in this study. Therefore it is conceivable that other families of proteases may also become induced in viral infections and lead to the induction of multiple signaling pathways, which would represent an area that merits further investigation.
Neutrophil-derived proteases have an important role in micro-flora clearance, with mice deficient in neutrophil granule proteases unable to resist staphylococcal and candidal infections. 3 However little is known about the antimicrobial functions of protease networks, especially those associated with viral infection. Prior to this study it was unclear whether the host protease response was required to clear the microbial infection or whether the protease release would have an overall negative impact on lung inflammation and remodeling. Due to the numerous proteases induced by RSV, it is out of the scope of this manuscript to investigate the functional role of each protease in response to RSV, but through the use of broadspectrum protease inhibitors we have determined the impact of proteases on RSV infection and airway hyperresponsiveness to metacholine challenge. Further work is required to determine whether the inhibition of IL-4 by protease inhibitors is the primary impact on preventing RSV-induced airway hyperresponsiveness by protease inhibitors or ribavirin. As IL-4 has a major role in allergic response to RSV infection through the development of airway hyperresponsiveness and lung eosinophilia; 25 it is conceivable that protease regulation of IL-4 may have a major role in disease symptoms. The beneficial effects of inhibiting cathepsins was surprising as cathepsin activity regulates TLR9 interaction with CpG, thereby regulating TLR9 immunity. 40 However recent evidence suggests that cathepsin S can lead to the formation of soluble TLR9 that inhibits TLR9 signaling. 41 Cathepsin S activity was inhibited by E64 and ribavirin. In fact, ribavirin inhibited cathepsin S gene expression. Recent studies suggest that several of the proteases highlighted in this study could contribute to macrophage migration, invasion, differentiation, and maturation, such as MMP-10, 42 MMP-19, 43 and MMP-28. 44 However, further studies are required to investigate their functional roles here.
In summary, our studies demonstrate that RSV acts in a RLR-dependent manner, most likely via RIG-I signaling via type-I IFN, to augment airway protease responses in the lung. Inhibition of protease activity prevented RSV-induced airway hyperresponsiveness and lead to enhanced clearance of the virus. These findings provide important new insights into the elaborate network of proteases triggered by RSV lung infection. METHODS RSV culture. Human RSV strain A2 (#VR-1540; ATCC, Manassas, VA) was cultured and virus titers were quantified in Hep2 cells by performing plaque assays, as previously described.
1 Briefly, the virus was allowed to grow for 5 days at 37 1C in a 5% CO 2 atmosphere. The infected Hep2 monolayers were collected and the virus was released by sonication. Cell debris was removed by centrifugation at 2,500 g for 5 min at 4 1C. Virus was collected by centrifuging the supernatant for 2 h at 22,000 g at 4 1C. Virus were suspended in culture media and snap frozen and maintained at À 80 o C. Noninfected Hep2 cell cultures were processed in the same manner as RSV-infected cells and the resulting sample collection was used as a mock control.
Animal models. Trif (Ticam1) and Mavs KO mice were purchased from the Jackson Laboratory (Bar Harbor, ME) and bred on to a Friend leukemia virus B sensitive strain background for at least six generations. All mice were maintained in a specific pathogen-free facility at the Mount Sinai Roosevelt's Hospital. Eight-week-old mice were used at the initiation point for all experiments and each experimental parameter had 12 animals per group. Mice were anesthetized by intraperitoneal injection of a mixture of ketamine and xylazine. Animals were intranasally administered 1 Â 10 6 plaque forming units of RSV or mock. Mock and RSV infection animals were killed every second day up to 9 days post challenge. Animals were weighed daily. BALF and lung tissue were collected for analysis of protease levels. Immune cell counts were determined by microscopy and cell type determined by quick diff staining. All animal experiments were performed with the approval from the Mount Sinai Roosevelt's Hospital Center's Institutional Animal Care and Use Committee approval at the Mount Sinai School of Medicine.
Lung titers and RSV N copy number. Lungs of infected mice were excised and homogenized using a mechanical homogenizer (Kinematica, Bohemia, NY). The viral titers in the homogenates were quantified by plaque assay on Hep2 cells, as previously described. 1 The concentration of RSV N (pg) was determined by PCR based on a standard curve. The following primers were used at 100 pmol each: 5 0 -TGG GAG AGG TAG CTC CAG AA-3 0 and 5 0 -AGA ATC TGT CCC CTG CTG CTA-3 0 . Cycle threshold was plotted against known RSV standards. Results are represented as natural log pico grams.
Cell culture. Monolayers of human SAE cells from healthy subjects (Lonza, Walkersville, MD) were submerged cultured. All cells are assayed and tested negative for HIV-1, mycoplasma, Hepatitis-B, Hepatitis-C, bacteria, yeast, and fungi upon isolation by Lonza. Cells were only used for experiments at passages 3-6 and at a confluency of B70%. SAE cells were transfected by administering siRNA for MDA5, RIG-I, Trif, MAVS, LGP2, IFNAR1, IFNAR2, or control siRNA (Qiagen, Gaithersburg, MD). Cells were treated with RSV at a multiplicity of infection of 0.3 for 24 h. Cells were also treated with mock control as described above. In addition, SAE cells were transfected with either an empty vector (pCMV6-Entry; Origene, Rockville, MD) or with the same vector that overexpresses RIG-I (DDX58) as recommended by the manufacturers (Origene). Human recombinant IFN-b protein (EMD Millipore, Billerica, MA) was administered to SAE cells at 1,000 U for 24 h.
MMP and cathepsin measurements. MMP and cathepsin gene expression was performed by qPCR using validated Taqman probes (Life Technologies/Applied Biosystems, Carlsbad, CA). All qPCR results are represented as relative quantification compared with the mock-treated animals and corrected to actin levels. Several MMP levels were measured in BALF and cell culture supernatants using a bead assay (MILLIPLEX MAP MMP Magnetic Bead Panels; EMD Millipore) with the Bio-Rad Bio-Plex 200 system (Bio-Rad Laboratories, Hercules, CA). Cathepsin tissue levels were determined by immunoblots and BALF cathepsin S and B activity assays as previously described. 45 Cathepsin G BALF activity was determined by a commercial available colorimetric assay (ab126780; Abcam, Cambridge, MA). BALF collagenase activity was determined by a colorimetric ninhydrin method, as previously described. 22 Proteinase activity was also assessed with the same colorimetric ninhydrin method but utilizing casein as the substrate. BALF elastase activity was measured by the hydrolysis of N-succinyl-L-Ala-LAla-L-Ala-p-nitroanilide per minute at 25 1C and pH 8.0. BALF gelatinase activity was determined by gelatin zymography.
Intracellular signaling. Lung tissue protein from mice was homogenized in radio-immunoprecipitation assay buffer, centrifuged at 13,000 g for 10 min and the supernatants were collected. Immunoblots were conducted to determine levels of cathepsins E, S, G, K, B, W, Z (all cathepsin antibodies where purchased from Santa Cruz Biotechnology, Paso Robles, CA), MDA5, RIG-I, MAVS, Trif, MyD88, phosphoryated-IFN regulatory factor 3(Ser396), IFN regulatory factor 3, phospho-TANK-binding kinase 1(Ser172), TANK-binding kinase 1/NAK, and actin (all remaining antibodies where purchased from Cell Signaling Technologies, Danvers, MA). Chemiluminescence detection was performed using the Molecular Imager ChemiDoc XRS þ imaging system (Bio-Rad Laboratories). Densitometry was performed on each target and represented as a ratio of pixel intensity compared with actin, using Image Lab software (version 4.0, build 16; Bio-Rad Laboratories). NF-kBp65 and activator protein 1 levels were measured in the nuclear protein extracts using specific activation assays from Active Motif (46096 and 40096; Active Motif, Carlsbad, CA). Relative transcription factor activity is represented as percentage compared with the mock-treated group.
Immunofluorescence. Immunoreactivity assays were performed on SAE cells with polyclonal anti-RSV (ab20745; Abcam), anti-MMP-9 (#2270; Cell Signaling Technologies), and anti-cathepsin E (sc-166343; Santa Cruz Biotechnology) antibodies. Mouse lung tissue was also examined for RSV immunoreactivity. Statistical analyses. For statistical analysis, data from 12 animals or multiple separate cell experiments were pooled. Data are expressed as means±s.e.m. Differences between groups of mice over time were compared by two-way analysis of variance. Individual differences between groups were tested by multiple comparison and analysis using the Bonferroni post-test. Pairs of groups were compared by Student's t-test (two tailed). P-values for significance were set at 0.05. All analysis was performed using GraphPad Prism Software (Version 5 for Mac OS X, GraphPad Software, Inc., La Jolla, CA).
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